share

Acumapimod (Bct-197) CAS NO 836683-15-9


Unit Price:

CAS No.:836683-15-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Acumapimod (BCT-197) is a potent and selective inhibitor of p38 mitogen-activated protein kinase (MAPK) alpha, a key signaling protein involved in inflammatory pathways. This compound matters for its significant role in preclinical research focused on modulating cytokine production and cellular stress responses. Pharmaceutical R&D teams and academic researchers in the fields of immunology, oncology, and inflammatory diseases require high-purity Acumapimod to investigate novel therapeutic mechanisms and validate drug targets.

Application

  • Pharmaceutical Research & Development: Serves as a critical reference standard and active pharmaceutical ingredient (API) intermediate in the development of novel anti-inflammatory and anti-cancer therapeutics.
  • Biochemical Assay Development: Used as a selective tool compound in high-throughput screening (HTS) and in vitro assays to study p38 MAPK signaling pathways and inhibitor efficacy.
  • Mechanism of Action Studies: Employed in cellular and animal models to elucidate the role of p38α in disease pathology, including rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and certain cancers.
  • Academic & Contract Research: Essential for universities and CROs conducting fundamental research on kinase biology, inflammation, and cell stress responses.
  • Preclinical Candidate Optimization: Used in structure-activity relationship (SAR) studies to design and optimize next-generation p38 inhibitors with improved potency and selectivity profiles.

Basic Information

Product Name Acumapimod (BCT-197)
CAS No. 836683-15-9
Molecular Formula C₂₀H₂₀N₆O₂
Molecular Weight 376.41 g/mol
Synonyms BCT-197; BCT197; 5-(2,6-Dichloro-4-pyridinyl)-3-[(1S)-1-(4-pyridinyl)ethyl]-1,3,4-oxadiazol-2(3H)-one; (S)-5-(2,6-Dichloropyridin-4-yl)-3-(1-(pyridin-4-yl)ethyl)-1,3,4-oxadiazol-2(3H)-one; p38 MAPK inhibitor BCT-197; Losmapimod analog; GW856553 analog
EINECS Contact for details

Quality Control

Our Acumapimod (BCT-197) is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity, suitable for research applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity (typically ≥98% by HPLC), and impurity profiles. We adhere to relevant industry standards for research chemicals, and specifications can be aligned with client requirements for advanced R&D use.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a cool, dry place. Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed and consideration should be given to storage under an inert atmosphere or with desiccant for long-term preservation.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Conforms to reference standard
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 98.0%
Related Substances (HPLC) Individual impurity ≤ 0.5% Total impurities ≤ 2.0%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.